Search Results - "Renovanz, Miriam"

Proposed definition of competencies for surgical neuro-oncology training by Kamp, Marcel A., Malzkorn, Bastian, von Sass, Christiane, DiMeco, Francesco, Hadjipanayis, Constantinos G., Senft, Christian, Rapp, Marion, Gepfner-Tuma, Irina, Fountas, Konstantinos, Krieg, Sandro M., Neukirchen, Martin, Florian, Ioan Ștefan, Schnell, Oliver, Mijderwijk, Hendrik-Jan, Perin, Alessandro, Baumgarten, Peter, van Lieshout, Jasper H., Thon, Niklas, Renovanz, Miriam, Kahlert, Ulf, Spoor, Jochem K. H., Hänggi, Daniel, McLean, Aaron Lawson, Mäurer, Matthias, Sarrubbo, Silvio, Freyschlag, Christian F., Schmidt, Nils O., Vergani, Francesco, Jungk, Christine, Stein, Marco, Forster, Marie-Therese, Weinberg, Jeffrey S., Sinclair, John, Belykh, Evgenii, Bello, Lorenzo, Mandonnet, Emmanuel, Moiyadi, Aliasgar, Sabel, Michael

“…Objective The aim of this work is to define competencies and entrustable professional activities (EPAs) to be imparted within the framework of surgical…”
Get full text

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial by Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C, Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang, Weller, Michael, Fimmers, Rolf, Schmid, Matthias, Hattingen, Elke, Pietsch, Torsten, Coch, Christoph, Glas, Martin

“…There is an urgent need for more effective therapies for glioblastoma. Data from a previous unrandomised phase 2 trial suggested that lomustine-temozolomide…”
Get full text

Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment by Renovanz, Mirjam, Kim, Ella L

Get full text